Clinical utility of monitoring sialyl Lewis(x) (CD15s) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
Ishida
H
H
Department of Surgery III, Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Koyama
I
I
Sawada
T
T
Murakami
T
T
Utsumi
K
K
Sannomiya
A
A
Tsuji
K
K
Tojimbara
T
T
Nakajima
I
I
Tanabe
K
K
Fuchinoue
S
S
Yamaguchi
Y
Y
Toma
H
H
Agishi
T
T
D000328:Adult; D005260:Female; D005434:Flow Cytometry; D006084:Graft Rejection / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D007983:Lewis Blood Group Antigens; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D015166:Monitoring, Immunologic; D009844:Oligosaccharides / Q000097:blood*; D011183:Postoperative Complications / Q000097:blood / Q000276:immunology; D000080506:Sialyl Lewis X Antigen
D007983:Lewis Blood Group Antigens; D009844:Oligosaccharides; D000080506:Sialyl Lewis X Antigen